Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_assertion type Assertion NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_head.
- NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_assertion description "[ARX mutation testing should be undertaken in children aged less than 1 year with Ohtahara syndrome and a movement disorder, and in infants with unexplained neurodegeneration, progressive white matter loss, and cortical atrophy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_provenance.
- NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_assertion evidence source_evidence_literature NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_provenance.
- NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_assertion SIO_000772 19747203 NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_provenance.
- NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_assertion wasDerivedFrom befree-20150227 NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_provenance.
- NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_assertion wasGeneratedBy ECO_0000203 NP978164.RANfkew49RS6nYW8E46Qs7zF1E8Qtwdu4O81EKMuBHX8A130_provenance.